119 results
8-K
HARP
Harpoon Therapeutics Inc
8 Mar 24
Submission of Matters to a Vote of Security Holders
4:04pm
Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties and actual results may differ materially from those … the proposed transaction in a timely manner or at all; (viii) significant costs associated with the proposed transaction; (ix) potential litigation relating
DEFA14A
HARP
Harpoon Therapeutics Inc
28 Feb 24
Additional proxy soliciting materials
7:37am
other things, the Merger.
Certain Litigation
In connection with the Merger, one complaint has been filed against Harpoon and its directors … in the Definitive Proxy Statement by purported Harpoon stockholders (the “Demands”).
Harpoon cannot predict the outcome of any litigation or the Demands
8-K
HARP
Harpoon Therapeutics Inc
28 Feb 24
Other Events
7:34am
other things, the Merger.
Certain Litigation
In connection with the Merger, one complaint has been filed against Harpoon and its directors … in the Definitive Proxy Statement by purported Harpoon stockholders (the “Demands”).
Harpoon cannot predict the outcome of any litigation or the Demands
DEFA14A
HARP
Harpoon Therapeutics Inc
22 Feb 24
Additional proxy soliciting materials
8:32am
that are not historical facts, may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 … associated with the proposed transaction; (ix) potential litigation relating to the proposed transaction; (x) restrictions during the pendency
8-K
HARP
Harpoon Therapeutics Inc
22 Feb 24
Other Events
8:31am
that are not historical facts, may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 … costs associated with the proposed transaction; (ix) potential litigation relating to the proposed transaction; (x) restrictions during the pendency
DEFM14A
ur321
8 Feb 24
Proxy related to merger
7:00am
PREM14A
dhj pc8wlvpcdw
29 Jan 24
Preliminary proxy related to merger
4:52pm
DFAN14A
7y0w3ms7366rgxfo
10 Jan 24
Additional proxy materials by non-management
5:05pm
DEFA14A
t9caes5
8 Jan 24
Additional proxy soliciting materials
5:20pm
DEFA14A
qnj06o
8 Jan 24
Additional proxy soliciting materials
5:16pm
DFAN14A
1vhsjza08xl
8 Jan 24
Additional proxy materials by non-management
5:15pm
DEFA14A
d7o0 791jd006087ph
8 Jan 24
Additional proxy soliciting materials
8:04am
8-K
EX-2.1
tyofaavuu28 x0su306q
8 Jan 24
Entry into a Material Definitive Agreement
8:01am
8-K
EX-99.2
8kgbqf3ac0
8 Jan 24
Entry into a Material Definitive Agreement
8:01am
8-K
kwt7566gn7ozko
8 Jan 24
Entry into a Material Definitive Agreement
8:01am
8-K
EX-99.1
e2ie djy8b5hx7s79w
8 Jan 24
Entry into a Material Definitive Agreement
8:01am
8-K
EX-99.1
kkwq66
9 Nov 23
Harpoon Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:11pm
8-K
0uhyr
23 Oct 23
Entry into a Material Definitive Agreement
7:45pm
8-K
EX-10.1
h4pka t42
23 Oct 23
Entry into a Material Definitive Agreement
7:45pm